CHPA applauds dextromethorphan bill
The Consumer Healthcare Products Association (CHPA) announced itssupport of the introduction of the Dextromethorphan DistributionAct of 2006 (H.R. 5280).
CHPA applauds dextromethorphan bill
The Consumer Healthcare Products Association (CHPA) announced its support of the introduction of the Dextromethorphan Distribution Act of 2006 (H.R. 5280). The bipartisan legislation, sponsored by Rep. Fred S. Upton (R, Mich.) and Rep. Rick Larsen (D, Wash.), seeks to prevent the unapproved sale and distribution of unfinished (powdered or bulk) dextromethorphan. Recently, substance abuse experts have noted sporadic reports of teens intentionally obtaining unfinished dextromethorphan to get high by consuming large amounts of the powder or mixing it with other drugs or alcohol.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.
